All Q1 FY27 results →
G

India Glycols Ltd

Q1 FY27Beverages

India Glycols Q1 FY27 earnings call: Revenue & Margins

Q1 FY27 earnings call: what management said on revenue, margins and capex.

Price₹264
Market cap₹2.0K Cr
P/E6.2
Updated18 Sept 2026
Read4 min read

The short version

India Glycols expects a healthy double-digit growth in the potable spirits segment (FY27), driven by deeper penetration in core states and new offerings in deluxe whiskey, rum, and semi-premium vodka segments. India Glycols aims to deliver an EBITDA in excess of INR 500 crores for FY27, with INR 120 crores already achieved in Q1.

From India Glycols Ltd's Q1 FY27 earnings-call transcript · updated 18 Sept 2026.

Revenue & Sales Performance

  • India Glycols expects a healthy double-digit growth in the potable spirits segment (FY27), driven by deeper penetration in core states and new offerings in deluxe whiskey, rum, and semi-premium vodka segments.
  • Aim to double volume from FY26 levels with premiumization leading to revenue growth outpacing volume growth.
  • Project EBITDA for potable spirits to exceed INR 500 crores in FY27 and target INR 1,000 crores within 4-5 years.
  • The IMFL segment is expected to contribute over 30% of potable spirits revenue.
  • The Ennature Bio Pharma segment aims for INR 130-150 crores EBITDA in 4-5 years, driven by growth in nicotine business and nutraceutical launches.

2 more points from India Glycols Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what India Glycols Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • For the NSU (Nutraceuticals and Specialty Units) segment, the planned capex for the current year is modest, approximately INR 5-20 crores, focusing on incremental and modular expansions rather than large-scale investments.
  • No major large-scale plant investments (INR 400-500 crores) are expected within the next 2 years.
  • Long-term aspiration includes growing the NSU business to INR 600-700 crores by 2030 with improving profitability.

2 more points from India Glycols Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Beverages

Ranked on what management guided this quarter

Guidance-ranked
1Piccadily Agro
Rev 1Mar 3
2Varun Beverages
Rev 2Mar 3
3
Rev 2Mar 3
4
Rev 3Mar 1
5
Rev 3Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what India Glycols Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

Relevant insights include: - Ennature Bio Pharma reported a strong order pipeline, supported by new customer acquisitions and nutraceutical launches. - The nicotine business capacity expansion and sales growth indicate increasing demand.

2 more points from India Glycols Ltd's call on order book

Create a free account to keep reading this call

India Glycols Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Q1 FY27 figures are not in this chart yet. Latest shown: Mar 2026 (Q4 FY26). The Q1 FY27 numbers from the filing are in the analysis on this page.

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹976 Cr, net profit ₹87 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Beverages this season

  • Suraj Industries (Q1 FY27)

    Revenue from operations for Q1FY27: Rs 73 Cr (Page 24) . Key investor presentation takeaways from Suraj Industries Ltd's Q1 FY27 investor presentation — and how

  • United Spirits (Q1 FY27)

    Marketing spends are steady at **10.5%-11% of net sales** to support brand investments and growth. Key concall takeaways from United Spirits Ltd's Q1 FY27…

  • Piccadily Agro (Q1 FY27)

    Whistler brand shows double-digit to higher double-digit growth, having grown almost 100% year-on-year in the last year. Key concall takeaways from Piccadily…

  • FratelliVineyard (Q1 FY27)

    The industry, particularly RTD, is growing at approximately 25% annually. Key concall takeaways from Fratelli Vineyards Ltd's Q1 FY27 earnings call — and how…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

India Glycols Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were India Glycols Ltd Q1 FY27 results?

India Glycols expects a healthy double-digit growth in the potable spirits segment (FY27), driven by deeper penetration in core states and new offerings in deluxe whiskey, rum, and semi-premium vodka segments. India Glycols aims to deliver an EBITDA in excess of INR 500 crores for FY27, with INR 120 crores already achieved in Q1.

What is India Glycols Ltd share price analysis?

India Glycols Ltd currently shows a neutral. The stock trades at a P/E of 6.2 with a market cap of ₹1,977 Cr. Investors should review the full earnings analysis for detailed insights.

Is India Glycols Ltd planning capital expenditure?

For the NSU (Nutraceuticals and Specialty Units) segment, the planned capex for the current year is modest, approximately INR 5-20 crores, focusing on incremental and modular expansions rather than large-scale investments.

Keep India Glycols Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.